Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PDL-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT06713798
What this trial is testing

Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures

Who this might be right for
Metastatic Cancer LungAdvanced Lung CancerCBNPC Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Large-scale testing (Phase 3)Study completedNCT04878016
What this trial is testing

Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Lee's Pharmaceutical Limited 498
Testing effectiveness (Phase 2)UnknownNCT05267392
What this trial is testing

Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy

Who this might be right for
Non-small Cell Lung Cancer
Instituto Portugues de Oncologia, Francisco Gentil, Porto 30
Early research (Phase 1)Study completedNCT04739111
What this trial is testing

An Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant Tumor

Who this might be right for
Advanced Malignant Tumor
Dragonboat Biopharmaceutical Company Limited 12
Not applicableStudy completedNCT02855281
What this trial is testing

Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer

Who this might be right for
Lung Neoplasms
Wissenschaftliches Institut Bethanien e.V 50
Testing effectiveness (Phase 2)UnknownNCT04396457
What this trial is testing

Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901

Who this might be right for
Non-squamous Non-small-cell Lung CancerCancer, Lung
National Hospital Organization Nagoya Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT05215067
What this trial is testing

A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-small Cell Lung Cancer
Akeso 44
Early research (Phase 1)Active Not RecruitingNCT06077500
What this trial is testing

DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma (SCLC)
Boehringer Ingelheim 46
Testing effectiveness (Phase 2)Study completedNCT03043664
What this trial is testing

Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
Duke University 22
Testing effectiveness (Phase 2)Study completedNCT06501378
What this trial is testing

Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis

Who this might be right for
NSCLC Stage IV
Fudan University 40
Testing effectiveness (Phase 2)Looking for participantsNCT04106115
What this trial is testing

DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr

Who this might be right for
Bladder Cancer
University College, London 52
Testing effectiveness (Phase 2)UnknownNCT03951415
What this trial is testing

Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer

Who this might be right for
Endometrial NeoplasmsUterine NeoplasmsEndometrium Cancer
Leiden University Medical Center 55
Early research (Phase 1)Study completedNCT03502330
What this trial is testing

APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma

Who this might be right for
Advanced MelanomaNon-small Cell Lung CancerRenal Cell Carcinoma
Yale University 42
Testing effectiveness (Phase 2)Ended earlyNCT06405230
What this trial is testing

Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 2
Large-scale testing (Phase 3)Active Not RecruitingNCT05116189
What this trial is testing

Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).

Who this might be right for
Ovarian CancerCarcinoma, Ovarian EpithelialFallopian Tube Neoplasms
Merck Sharp & Dohme LLC 643
Early research (Phase 1)UnknownNCT04118868
What this trial is testing

Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma.

Who this might be right for
Mycosis Fungoides
Sorrento Therapeutics, Inc. 10
Not applicableStudy completedNCT03258788
What this trial is testing

A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
The Christie NHS Foundation Trust 15
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06538935
What this trial is testing

SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaSBRTImmune Checkpoint Blockade+1 more
Fujian Cancer Hospital 80
Early research (Phase 1)UnknownNCT03283943
What this trial is testing

PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.

Who this might be right for
Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer
British Columbia Cancer Agency 22
Next Page